Evidence map›Paper›PMID 30956827›Full record

ArticleCase reports in nephrology2019

Late-Onset Neutropenia after Rituximab Treatment for Adult-Onset Nephrotic Syndrome.

Mayuko Yamazaki, Hidekazu Sugiura, Yosuke Iwatani, Mizuki Kyoda, Hirohiko Nokiba, Nobuyuki Amemiya, Kosaku Nitta, Ken Tsuchiya

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mayuko YamazakiDepartment of Nephrology, Division of Medicine, Saiseikai Kurihashi Hospital, Saitama, Japan.ORCID 0000-0003-1797-1711
Hidekazu SugiuraDepartment of Nephrology, Division of Medicine, Saiseikai Kurihashi Hospital, Saitama, Japan.
Yosuke IwataniDepartment of Nephrology, Division of Medicine, Saiseikai Kurihashi Hospital, Saitama, Japan.
Mizuki KyodaDepartment of Nephrology, Division of Medicine, Saiseikai Kurihashi Hospital, Saitama, Japan.
Hirohiko NokibaDepartment of Nephrology, Division of Medicine, Saiseikai Kurihashi Hospital, Saitama, Japan.
Nobuyuki AmemiyaDepartment of Nephrology, Division of Medicine, Saiseikai Kurihashi Hospital, Saitama, Japan.
Kosaku NittaDepartment of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
Ken TsuchiyaDepartment of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
Tokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 41-year-old woman developed nephrotic syndrome at the age of 32 and was diagnosed with minimal change nephrotic syndrome based on a renal biopsy. Although remission was achieved with administration of prednisolone (PSL) and cyclosporine, the nephrotic syndrome recurred. She was also started on rituximab (RTX). She developed late-onset neutropenia after RTX treatment (R-LON) and improved 17 days later. Although the majority of R-LON cases undergo spontaneous remission, cases of death have been reported. This report is intended to warn about R-LON, since the use of RTX for adult-onset nephrotic syndrome is expected to increase in the future.

Identifiers

PMID30956827
PMCPMC6425356
OpenAlexW2919834881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.